1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow pirarubicin: new trials by email Literature Review of pirarubicin trials Research Report on pirarubicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC QL1706 (bispecific antibody targeting PD-1 and CLTA-4), Pirarubicin, Nab-paclitaxel - TNBC, Triple Negative Breast Cancer | Phase 1 | Recruiting | Xijing Hospital | 30 | 2025-11-06 | 2025-11-24 |
Triple Negative Breast Neoplasms (1)
Xijing Hospital (1)
China (1)